Brought to you by 
P&G, Teva bring together their OTC products; JV to dissolve
27 Apr 2018
Executive Summary
Procter & Gamble Co. and Teva Pharmaceutical Industries Ltd. have created a joint venture of their OTC businesses worldwide, excluding North America. The deal is expected to increase the number of distribution channels and regions where these consumer products are available.
Deal Industry
- Pharmaceuticals
-
Pharmaceuticals
- OTC, Consumer
Deal Status
- Terminated
Deal Type
-
Alliance
- Joint Venture
- Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
P&G, Teva bring together their OTC products; JV to dissolve
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice